Seguir
Isabel Rodríguez-Barraquer
Isabel Rodríguez-Barraquer
Dirección de correo verificada de ucsf.edu - Página principal
Título
Citado por
Citado por
Año
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
AT Huang, B Garcia-Carreras, MDT Hitchings, B Yang, LC Katzelnick, ...
Nature communications 11 (1), 4704, 2020
10972020
Assessing the global threat from Zika virus
J Lessler, LH Chaisson, LM Kucirka, Q Bi, K Grantz, H Salje, AC Carcelen, ...
Science 353 (6300), aaf8160, 2016
4532016
Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region
I Rodriguez-Barraquer, F Costa, EJM Nascimento, N Nery, PMS Castanha, ...
Science 363 (6427), 607-610, 2019
2762019
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
NM Ferguson, I Rodríguez-Barraquer, I Dorigatti, L Mier-y-Teran-Romero, ...
Science 353 (6303), 1033-1036, 2016
2762016
Reconstruction of antibody dynamics and infection histories to evaluate dengue risk
H Salje, DAT Cummings, I Rodriguez-Barraquer, LC Katzelnick, J Lessler, ...
Nature 557 (7707), 719-723, 2018
2562018
The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study
S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ...
PLoS medicine 13 (11), e1002181, 2016
2132016
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
ST Tan, AT Kwan, I Rodríguez-Barraquer, BJ Singer, HJ Park, ...
Nature Medicine 29 (2), 358-365, 2023
2102023
Mapping global variation in dengue transmission intensity
L Cattarino, I Rodriguez-Barraquer, N Imai, DAT Cummings, ...
Science translational medicine 12 (528), eaax4144, 2020
2102020
From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil
I Rodriguez-Barraquer, MT Cordeiro, C Braga, WV de Souza, ET Marques, ...
PLoS neglected tropical diseases 5 (1), e935, 2011
1932011
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
MJ Peluso, AN Deitchman, L Torres, NS Iyer, SE Munter, CC Nixon, ...
Cell Reports 36 (6), 2021
1912021
Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations
B Sun, N Tang, MJ Peluso, NS Iyer, L Torres, JL Donatelli, SE Munter, ...
Cells 10 (2), 386, 2021
1822021
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
JE Bryant, AS Azman, MJ Ferrari, BF Arnold, MF Boni, Y Boum, K Hayford, ...
Science immunology 5 (47), eabc6347, 2020
1672020
Enhancing disease surveillance with novel data streams: challenges and opportunities
BM Althouse, SV Scarpino, LA Meyers, JW Ayers, M Bargsten, ...
EPJ data science 4 (1), 1-8, 2015
1622015
Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure
I Rodriguez-Barraquer, E Arinaitwe, P Jagannathan, MR Kamya, ...
Elife 7, e35832, 2018
1442018
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
MJ Peluso, S Takahashi, J Hakim, JD Kelly, L Torres, NS Iyer, K Turcios, ...
Science advances 7 (31), eabh3409, 2021
1402021
Unraveling the drivers of MERS-CoV transmission
S Cauchemez, P Nouvellet, A Cori, T Jombart, T Garske, H Clapham, ...
Proceedings of the national academy of sciences 113 (32), 9081-9086, 2016
1272016
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study
C Andolina, JC Rek, J Briggs, J Okoth, A Musiime, J Ramjith, N Teyssier, ...
The Lancet Infectious Diseases 21 (11), 1568-1578, 2021
1212021
Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children
LC Rubiano, MIC Miranda, S Muvdi Arenas, LM Montero, ...
Journal of Infectious Diseases 205 (4), 684-692, 2012
1182012
Long-term circulation of Zika virus in Thailand: an observational study
K Ruchusatsawat, P Wongjaroen, A Posanacharoen, ...
The Lancet Infectious Diseases 19 (4), 439-446, 2019
1142019
Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus
LC Katzelnick, A Coello Escoto, BD McElvany, C Chávez, H Salje, W Luo, ...
PLoS neglected tropical diseases 12 (10), e0006862, 2018
992018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20